Education
About Us
Working with TipRanks
Follow Us
Barry Kitt Insider Profile
4 Followers
Barry Kitt, Ten Percent Owner at China Biologic, holds 5.30M shares in Quest Resource (Ticker: QRHC), holds 1.88M shares in Dyadic International (Ticker: DYAI), holds 3.86M shares in China Valves Technology (Ticker: CVVT). Most recently, Barry Kitt Bought ― shares of Quest Resource on Oct 27, 2025 for an estimated value of $259.99K.
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
+1.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Barry Kitt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Barry Kitt
Barry Kitt's Trading History
China Biologic
Jun 09, 2009
―
Informative Sell
3.67M
$37.39M
China Valves Technology
Feb 11, 2010
―
Informative Sell
5.33M
―
Yuhe International
Jun 30, 2009
Ten Percent Owner
Informative Sell
1.49M
―
Dyadic International
Jan 05, 2016
Ten Percent Owner
Informative Buy
―
$1.76M
Quest Resource
Oct 27, 2025
Ten Percent Owner
Informative Buy
259.99K
$7.69M
Nuverra Environmental Solutions Inc
―
―
―
$71.07M
Taoping
―
Ten Percent Owner
―
$0.00
Manitex International
Jul 28, 2009
―
Informative Sell
369.39K
$6.24M
Nuverra Environmental Solutions
Jun 18, 2009
―
Informative Sell
6.95M
$12.87M
List of latest transactions for each holding click on a transaction to see Barry Kitt's performance on stock
You May Also Like
Barry Kitt insider profile FAQ
What is the percentage of profitable transactions made by Barry Kitt?
The percentage of profitable transactions made by Barry Kitt is 33%.
What is the average return per transaction made by Barry Kitt?
The average return per transaction made by Barry Kitt is 1.80%.
What stocks does Barry Kitt hold?
Barry Kitt holds: CBPO, CVVT, YUII, DYAI, QRHC, NESCQ, TAOP, MNTX, NES stocks.
What was Barry Kitt’s latest transaction?
Barry Kitt latest transaction was an Informative Buy of $259.99K.
What was Barry Kitt's most profitable transaction?
Barry Kitt’s most profitable transaction was an Informative Buy of QRHC stock on December 7, 2021. The return on the trade was 19.40%.
What is Barry Kitt's role in China Biologic?
Barry Kitt's role in China Biologic is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.